Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS)
CNY 8.56
(0.59%)
CNY 8.56
(0.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 604.04 Million | 444.37 Million | 149.32 Million | 234.55 Million | 361.86 Million | 351.08 Million |
| Net Income | 246.17 Million | 143.11 Million | 83.47 Million | 233.48 Million | 128.78 Million | 173.43 Million |
| Depreciation & Amortization | 382.56 Million | 348.12 Million | 303.19 Million | 243.93 Million | 186.93 Million | 157.93 Million |
| Deferred income taxes | -5.04 Million | -4.32 Million | -2.28 Million | 3.25 Million | -1.49 Million | -5.27 Million |
| Stock-based compensation | 1.33 Million | 3.92 Million | 7.96 Million | 9.13 Million | 2.38 Million | - |
| Change in working capital | -169.78 Million | -220.3 Million | -378.78 Million | -132.91 Million | -75.7 Million | -95.92 Million |
| Other non-cash items | 1.08 Billion | 173.84 Million | 135.76 Million | -122.34 Million | 120.96 Million | 115.65 Million |
| Investing Cash Flow | -307.92 Million | -444 Million | -512.99 Million | -557.93 Million | -396.85 Million | -1.1 Billion |
| Investments in PPE | -337.91 Million | -428.36 Million | -486.74 Million | -703.11 Million | -828.6 Million | -855.23 Million |
| Acquisitions | 64.01 Million | 41.91 Million | 1.22 Million | 217.3 Million | 242.44 Million | 155.94 Million |
| Investment purchases | -34.44 Thousand | -15.82 Million | -42.18 Million | -50.38 Million | -242.44 Million | -422.99 Million |
| Sales/Maturities of investments | 34.44 Thousand | 29.52 Thousand | 19.72 Million | 5.11 Million | 265.99 Million | 95.75 Million |
| Other Investing Activities | -34.02 Million | -41.75 Million | -5.01 Million | -26.84 Million | 165.76 Million | -74.81 Million |
| Financing Cash Flow | -155.8 Million | -5.3 Million | 290.87 Million | 197.31 Million | -120.07 Million | 940.03 Million |
| Debt repayment | -131.42 Million | -1.97 Billion | -2.14 Billion | -1.96 Billion | -1.18 Billion | -637.19 Million |
| Dividends payments | -48.89 Million | -44.11 Million | -48.41 Million | -39.61 Million | -27.08 Million | -107.84 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 24.51 Million | 2.1 Billion | 2.57 Billion | 2.28 Billion | 1.18 Billion | 1.68 Billion |
| Accounts receivables | -124.56 Million | -516.06 Million | -83.45 Million | -517.64 Million | -189.73 Million | -145.12 Million |
| Accounts payables | -53.29 Million | 614.76 Million | 78.61 Million | 408.26 Million | 172.56 Million | 194.46 Million |
| Inventory | 7.61 Million | -314.68 Million | -367.16 Million | -26.79 Million | -57.04 Million | -139.99 Million |
| Other working capital | 451.31 Thousand | -4.32 Million | -6.78 Million | 3.25 Million | -1.49 Million | 44.06 Million |
| Cash at beginning of period | 688.81 Million | 385.51 Million | 436.3 Million | 563.65 Million | 719.56 Million | 529.47 Million |
| Cash at end of period | 798.46 Million | 387.03 Million | 364.34 Million | 436.3 Million | 563.65 Million | 719.56 Million |
| Capital Expenditure | -337.91 Million | -428.36 Million | -486.74 Million | -703.11 Million | -828.6 Million | -855.23 Million |
| Effect of forex changes on cash | 2.7 Million | 6.45 Million | 827.55 Thousand | -1.27 Million | -858.81 Thousand | 317.46 Thousand |
| Net cash flow / Change in cash | 109.65 Million | 1.52 Million | -71.95 Million | -127.34 Million | -155.91 Million | 190.08 Million |
| Free Cash Flow | 266.12 Million | 16.01 Million | -337.41 Million | -468.56 Million | -466.73 Million | -504.15 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 47.09 Million | 232.65 Million | 67.3 Million | 53.62 Million | 246.17 Million | 61.17 Million |
| Depreciation & Amortization | - | 96.41 Million | 96.41 Million | 93.5 Million | 382.56 Million | -194.68 Million |
| Deferred income taxes | - | - | - | - | -5.04 Million | 421.19 Million |
| Stock-based compensation | - | 24.74 Million | - | 1.33 Million | 1.33 Million | -1.02 Million |
| Change in working capital | - | -173.6 Million | - | -116.49 Million | -169.78 Million | -225.48 Million |
| Other non-cash items | 173.89 Million | -115.35 Million | 95.54 Million | -3.66 Million | 1.08 Billion | 14.08 Million |
| Investing Cash Flow | -43.28 Million | -38.89 Million | -94.53 Million | -22.13 Million | -307.92 Million | -94.41 Million |
| Investments in PPE | -50.98 Million | -30.11 Million | -83.01 Million | -92.71 Million | -337.91 Million | -81.16 Million |
| Acquisitions | 19.98 Million | 165.75 Thousand | - | 63.89 Million | 64.01 Million | 119.25 Thousand |
| Investment purchases | - | - | - | - | -34.44 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 34.44 Thousand | - |
| Other Investing Activities | 7.69 Million | -8.94 Million | -11.52 Million | 6.68 Million | -34.02 Million | -13.36 Million |
| Financing Cash Flow | -115.97 Million | -13.92 Million | -58.39 Million | -8.57 Million | -155.8 Million | -67.95 Million |
| Debt repayment | -83.32 Million | -72.51 Million | -45 Million | -185.58 Million | -131.42 Million | -662.16 Million |
| Dividends payments | -42.52 Million | -93.8 Million | -13.51 Million | -22.74 Million | -48.89 Million | -70.39 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 9.87 Million | -86.44 Million | -13.39 Million | 199.74 Million | 24.51 Million | 664.6 Million |
| Accounts receivables | - | -350.56 Million | - | -124.56 Million | -124.56 Million | -255.01 Million |
| Accounts payables | - | - | - | - | -53.29 Million | - |
| Inventory | - | 176.95 Million | - | 7.61 Million | 7.61 Million | 29.53 Million |
| Other working capital | - | - | - | 451.31 Thousand | 451.31 Thousand | - |
| Cash at beginning of period | 515.88 Million | 899.28 Million | 798.46 Million | 563.79 Million | 688.81 Million | 503.06 Million |
| Cash at end of period | 575.42 Million | 787.77 Million | 899.28 Million | 798.46 Million | 798.46 Million | 415.8 Million |
| Capital Expenditure | -50.98 Million | -30.11 Million | -83.01 Million | -92.71 Million | -337.91 Million | -81.16 Million |
| Effect of forex changes on cash | -2.18 Million | 7.74 Million | 130.12 Thousand | 1.48 Million | 2.7 Million | -139.04 Thousand |
| Net cash flow / Change in cash | 59.53 Million | -111.5 Million | 100.82 Million | 234.66 Million | 109.65 Million | -87.25 Million |
| Free Cash Flow | 169.99 Million | -9.23 Million | 79.83 Million | 50.75 Million | 266.12 Million | -5.91 Million |
1171
688513
SBW
5162
0F2S
200541